-
-
-
-
-
-
-
Eyenovia Inc (EYEN) Announces FDA Approval of Coastline International as Contract Manufacturer to Initiate Mydcombi Commercial Production
-
-
-
-
-
-
-
Eyenovia Inc (EYEN) Acquires U.S. Commercial Rights to APP13007
-
-
-
-
-
-
-
Eyenovia Announces FDA Acceptance of New Drug Application for MydCombi™ for In-Office Pupil Dilation
-
-
-
-
-
-
-
Eyenovia Inc (EYEN) Announces Positive Topline Results from VISION-1 Phase 3 Clinical Study of MicroLine for the Treatment of Presbyopia
-
-
-
-
-
-
-
Eyenovia Announces Publication of MIST Pivotal Studies Demonstrating the Efficacy and Safety of its MAP™ Fixed-Combination Tropicamide-Phenylephrine Product for Mydriasis
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

